Cargando…
Recurrent In Situ Melanoma Successfully Treated with Ingenol Mebutate
BACKGROUND: Treatment options for melanoma in situ (MIS) include imiquimod, radiation therapy, cryotherapy, excisional and Mohs surgery. Ingenol mebutate is a new topical treatment option recognized for actinic keratosis. Although in vitro effectiveness has been demonstrated on melanoma cell lines,...
Autores principales: | Mansuy, Marion, Nikkels-Tassoudji, Nazli, Arrese, Jorge E., Rorive, Andree, Nikkels, Arjen F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065276/ https://www.ncbi.nlm.nih.gov/pubmed/24691652 http://dx.doi.org/10.1007/s13555-014-0051-4 |
Ejemplares similares
-
Pachyderma in Primary Cutaneous NK and T-Cell Lymphoma and Leukemia Cutis
por: Lebas, Eve, et al.
Publicado: (2017) -
Ingenol mebutate treatment in keloids
por: De Felice, Bruna, et al.
Publicado: (2015) -
Tattoo removal with ingenol mebutate
por: Cozzi, Sarah-Jane, et al.
Publicado: (2017) -
Granulomatous Reactions from Tattoos Following BRAF Inhibitor Therapy
por: Giet, Gabrielle, et al.
Publicado: (2019) -
Hair Loss after Varicella Zoster Virus Infection
por: Hayderi, Lara El, et al.
Publicado: (2013)